BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/11/2024 6:17:31 AM | Browse: 219 | Download: 1088
 |
Received |
|
2023-08-19 11:21 |
|
Peer-Review Started |
|
2023-08-19 11:22 |
|
First Decision by Editorial Office Director |
|
2023-10-09 05:17 |
|
Return for Revision |
|
2023-10-10 09:51 |
|
Revised |
|
2023-10-26 03:56 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-12-03 23:53 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-12-11 07:55 |
|
Articles in Press |
|
2023-12-11 07:55 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-01-04 06:32 |
|
Publish the Manuscript Online |
|
2024-01-11 06:17 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
C-reactive protein to albumin ratio predict responses to programmed cell death-1 inhibitors in hepatocellular carcinoma patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Bai-Bei Li, Lei-Jie Chen, Shi-Liu Lu, Biao Lei, Gui-Lin Yu and Shui-Ping Yu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education |
GKE-ZZ202117 |
| the Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education |
GKE-ZZ202334 |
|
| Corresponding Author |
Shui-Ping Yu, MD, Chief Physician, Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, No. 22 Shuangyong Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. 478517575@qq.com |
| Key Words |
C-reactive protein to albumin ratio; Hepatocellular carcinoma; Programmed cell death-1 inhibitors; Prognosis; Nomogram |
| Core Tip |
This study suggests that the ratio of C-reactive protein to albumin (CAR), already studied as prognosticator in other malignancies may also have a useful role to predict the outcome of hepatocellular carcinoma (HCC). Our study found that higher CAR levels are associated with poor prognosis in patients with HCC treated with programmed cell death-1 inhibitors. Nomogram based on CAR can also be used for prognostic risk stratification. |
| Publish Date |
2024-01-11 06:17 |
| Citation |
Li BB, Chen LJ, Lu SL, Lei B, Yu GL, Yu SP. C-reactive protein to albumin ratio predict responses to programmed cell death-1 inhibitors in hepatocellular carcinoma patients. World J Gastrointest Oncol 2024; 16(1): 61-78 |
| URL |
https://www.wjgnet.com/1948-5204/full/v16/i1/61.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v16.i1.61 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
